Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma?

Oral Oncology

Volumn 51, Issue 3, 2015, Pages 229-236

  Mirghani, H ^a   Amen, F ^b   Moreau, F ^c   Lacau St Guily, J ^c  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

HPV; Non drinkers non smokers; Oral oropharyngeal oral cavity head and neck cancer; Young patients

Indexed keywords

PROTEIN P16; VIRUS ANTIBODY; VIRUS DNA;

CANCER PATIENT; CANCER RISK; CARCINOGENESIS; GENE OVEREXPRESSION; HUMAN; IN SITU HYBRIDIZATION; MOUTH CAVITY; MOUTH SQUAMOUS CELL CARCINOMA; OROPHARYNX; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SEROLOGY; SYSTEMATIC REVIEW (TOPIC); TONGUE CANCER; TONSIL; VIRUS ONCOGENE; VIRUS TRANSCRIPTION; WART VIRUS; GENETICS; MOUTH TUMOR; PAPILLOMAVIRIDAE; PATHOGENICITY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; HUMANS; MOUTH NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS;

EID: 84923081615     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2014.11.011     Document Type: Review

References (83)

1. J. Ferlay, and P. Pisani GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC cancer base (2002 estimates) 2004 IARC Press Lyon
2. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
3. S. Warnakulasuriya Global epidemiology of oral and oropharyngeal cancer Oral Oncol 45 2009 309 316
4. E.M. Sturgis, and P.M. Cinciripini Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110 2007 1429 1435
5. V. Bouvard, R. Baan, and K. Straif WHO international agency for research on cancer monograph working group. A review of human carcinogens - Part B: Biological agents Lancet Oncol 10 2009 321 322
6. A.K. Chaturvedi, E.A. Engels, and R.M. Pfeiffer Human papillomavirus and rising oropharyngeal cancer incidence in the United States J Clin Oncol 29 2011 4294 4301
7. J. Chenevert, and S. Chiosea Incidence of human papillomavirus in oropharyngeal squamous cell carcinomas: now and 50 years ago Hum Pathol 43 2012 17 22
8. E. Garnaes, K. Kiss, and L. Andersen A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000-2010: the largest registry-based study to date Int J Cancer 2014 Oct 4 10.1002/ijc.29254
9. G. D'Souza, Y. Agrawal, J. Halpern, S. Bodison, and M.L. Gillison Oral sexual behaviors associated with prevalent oral human papillomavirus infection J Infect Dis 199 2009 1263 1269
10. M. Frisch, H. Hjalgrim, A.B. Jaeger, and R.J. Biggar Changing patterns of tonsillar squamous cell carcinoma in the United States Cancer Causes Control 11 2000 489 495
11. J. Chenevert, R.R. Seethala, E.L. Barnes, and S.I. Chiosea Squamous cell carcinoma metastatic to neck from an unknown primary: the potential impact of modern pathologic evaluation on perceived incidence of human papillomavirus-positive oropharyngeal carcinoma prior to 1970 Laryngoscope 122 2012 793 796
12. S.J. Smeets, B.J. Braakhuis, and S. Abbas Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus Oncogene 25 2006 2558 2564
13. A.C. Jung, J. Briolat, and R. Millon Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oro-pharynx squamous cell carcinoma Int J Cancer 126 2010 1882 1894
14. H. Mirghani, F. Amen, and P. Blanchard Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives Int J Cancer 2014 Mar 13 10.1002/ijc.28847
15. J.D. Combes, and S. Franceschi Role of human papillomavirus in non-oropharyngeal head and neck cancers Oral Oncol 50 5 2014 370 379
16. M.L. Gillison, W.M. Koch, R.B. Capone, M. Spafford, W.H. Westra, and L. Wu Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720
17. C.C. Ragin, E. Taioli, J.L. Weissfeld, J.S. White, K.M. Rossie, and F. Modugno 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours Br J Cancer 95 2006 1432 1438
18. E.M. Smith, L.M. Rubenstein, T.H. Haugen, M. Pawlita, and L.P. Turek Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease J Oncol 2012 2012 571862
19. A. Sharma, E. Mendez, B. Yueh, P. Lohavanichbutr, J. Houck, and D.R. Doody Human papillomavirus-positive oral cavity and oropharyngeal cancer patients do not have better quality-of-life trajectories Otolaryngol Head Neck Surg 146 2012 739 745
20. J.P. Klussmann, S.J. Weissenborn, U. Wieland, V. Dries, J. Kolligs, and M. Jungehuelsing Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas Cancer 92 2001 2875 2884
21. S.J. Smeets, A.T. Hesselink, and E.J. Speel A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen Int J Cancer 121 2007 2465 2472
22. J.L. St Guily, A.C. Jacquard, J.L. Pretet, J. Haesebaert, A. Beby-Defaux, and C. Clavel Human papillomavirus genotype distribution in oropharynx and oral cavitycancer in France - the EDiTH VI study J Clin Virol 51 2011 100 104
23. J. Rautava, J. Kuuskoski, K. Syrjanen, R. Grenman, and S. Syrjanen HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas J Clin Virol 53 2012 116 120
24. J. Laco, J. Nekvindova, V. Novakova, P. Celakovsky, H. Dolezalova, and L. Tucek Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status Neoplasma 59 2012 398 408
25. K.B. Ribeiro, J.E. Levi, M. Pawlita, S. Koifman, E. Matos, and J. Eluf-Neto Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions Int J Epidemiol 40 2011 489 502
26. Z. Deng, M. Hasegawa, A. Kiyuna, S. Matayoshi, T. Uehara, and S. Agena Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma Head Neck 35 2013 800 808
27. A. Barwad, S. Sood, N. Gupta, A. Rajwanshi, N. Panda, and R. Srinivasan Human papilloma virus associated head and neck cancer: a PCR based study Diagn Cytopathol 40 2012 893 897
28. E. Kaminagakura, L.L. Villa, M.A. Andreoli, J.S. Sobrinho, J.G. Vartanian, and F.A. Soares High-risk human papillomavirus in oral squamous cell carcinoma of young patients Int J Cancer 130 2012 1726 1732
29. A.M. Chang, S.W. Kim, and U. Duvvuri Early squamous cell carcinoma of the oral tongue:comparing margins obtained from the glossectomy specimen to margins from the tumor bed Oral Oncol 49 2013 1077 1082
30. T. Isayeva, Y. Li, D. Maswahu, and M. Brandwein-Gensler Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review Head Neck Pathol 6 Suppl 1 2012 S104 20
31. A.R. Kreimer, G.M. Cifford, P. Boyle, and S. Franceschi Human Papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review Cancer Epidemiol Biomarkers Prev 14 2005 467 475
32. N. Termine, V. Panzarella, and S. Falaschini HPV in oral squamous cell carcinoma vs. head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007) Ann Oncol 19 2008 1681 1690
33. R. Herrero, X. Castellsague, M. Pawlita, J. Lissowska, F. Kee, and P. Balaram Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study J Natl Cancer Inst 95 2003 1772 1783
34. B. Klingenberg, H.C. Hafkamp, and A. Haesevoets P16 INK4A overexpression is frequently detected in tumour-free tonsil tissue without association with HPV Histopathology 56 2010 957 967
35. V.M. Van Houten, P.J. Snijders, and M.W. van den Brekel Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas Int J Cancer 93 2001 232 235
36. H. zur Hausen Papillomaviruses and cancer: from basic studies to clinical application Nat Rev Cancer 2 2002 342 350
37. T. Rampias, C. Sasaki, P. Weinberger, and A. Psyrri E6 and E7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells J Natl Cancer Inst 101 2009 412 423
38. S.J. Smeets, M. van der Plas, and T.B. Schaaij-Visser Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways Int J Cancer 128 2011 1596 1605
39. T. Wiest, E. Schwarz, C. Enders, C. Flechtenmacher, and F.X. Bosch Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control Oncogene 21 2002 1510 1517
40. A.C. Jung, J. Briolat, and R. Millon Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma Int J Cancer 126 2010 1882 1894
41. R.C. Jordan, M.W. Lingen, and B. Perez-Ordonez Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials Am J Surg Pathol 36 2012 945 954
42. B.J. Braakhuis, P.J. Snijders, and W.J. Keune Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus J Natl Cancer Inst 96 2004 998 1006
43. E. Tsimplaki, E. Argyri, D. Xesfyngi, D. Daskalopoulou, D.J. Stravopodis, and E. Panotopoulou Prevalence and expression of human papillomavirus in 53 patients with oral tongue squamous cell carcinoma Anticancer Res 34 2014 1021 1025
44. J.S. Lewis Jr, O.C. Ukpo, and X.J. Ma Transcriptionally-active high-risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas - a tissue microarray study utilizing E6/E7 mRNA in situ hybridization Histopathology 60 2012 982 991
45. J.S. Poling, X.J. Ma, and S. Bui Human papillomavirus (HPV) status of non-tobacco related squamous cell carcinomas of the lateral tongue Oral Oncol 50 2014 306 310
46. M.W. Lingen, W. Xiao, and A. Schmitt Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas Oral Oncol 49 2013 1 8
47. J.A. Bishop, X.J. Ma, and H. Wang Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method Am J Surg Pathol 36 2012 1874 1882
48. F. Bussu, M. Sali, and R. Gallus HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? Br J Cancer 108 2013 1157 1162
49. A.G. Schache, T. Liloglou, and J.M. Risk Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma Br J Cancer 108 2013 1332 1339
50. O.C. Ukpo, J.J. Flanagan, X.J. Ma, Y. Luo, W.L. Thorstad, and J.S. Lewis Jr. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma Am J Surg Pathol 35 2011 1343 1350
51. D. Rischin, R.J. Young, and R. Fisher Prognostic significance of p16INK4A and human papillomavirus in patients with oropha-ryngeal cancer treated on TROG 02.02 phase III trial J Clin Oncol 28 2010 4142 4148
52. J.S. Lewis Jr. P16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma Head Neck Pathol 6 2012 75 82
53. S.K. El-Mofty, and D.W. Lu Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity Am J Surg Pathol 27 2003 1463 1470
54. S.L. Harris, L.B. Thorne, W.T. Seaman, D.N. Hayes, M.E. Couch, and R.J. Kimple Association of p16(INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue Head Neck 33 2011 1622 1627
55. A.G. Schache, T. Liloglou, and J.M. Risk Evaluation of human Papillomavirus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination Clin Cancer Res 17 2011 6262 6271
56. B. Wasylyk, J. Abecassis, and A.C. Jung Identification of clinically relevant HPV-related HNSCC: in p16 should we trust? Oral Oncol 49 2013 33 37
57. R.P. Viscidi, K.L. Kotloff, B. Clayman, K. Russ, S. Shapiro, and K.V. Shah Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women Clin Diagn Lab Immunol 4 1997 122 126
58. J. Mork, A.K. Lie, and E. Glattre Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck N Engl J Med 344 2001 1125 1131
59. A.R. Kreimer, M. Johansson, and T. Waterboer Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer J Clin Oncol 31 2013 2708 2715
60. D. Anantharaman, T. Gheit, and T. Waterboer Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study J Natl Cancer Inst 105 2013 536 545
61. M. Toner, and E.M. O'Regan Head and neck squamous cell carcinoma in the young: a spectrum or a distinct group? Part 1 Head Neck Pathol 3 2009 246 248
62. E.M. O'Regan, M.E. Toner, and S.P. Finn P16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas Hum Pathol 39 2008 452 458
63. T.J. Siebers, M.A. Merkx, P.J. Slootweg, W.J. Melchers, P. van Cleef, and P.C. de Wilde No high-risk HPV detected in SCC of the oral tongue in the absolute absence of tobacco and alcohol - a case study of seven patients Oral Maxillofac Surg 12 2008 185 188
64. J. Brägelmann, I. Dagogo-Jack, and M. El Dinali Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA Oral Oncol 49 2013 525 533
65. X.H. Liang, J. Lewis, R. Foote, D. Smith, and D. Kademani Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience J Oral Maxillofac Surg 66 2008 1875 1880
66. M. Kabeya, R. Furuta, K. Kawabata, S. Takahashi, and Y. Ishikawa Prevalence of human papillomavirus in mobile tongue cancer with particular reference to young patients Cancer Sci 103 2012 161 168
67. B. Braakhuis, M. Rietbergen, and M. Buijze TP53 mutation and human papilloma virus status of oral squamous cell carcinomas in young adult patients Oral Dis 2013 Aug 23 10.1111/odi.12178
68. H. Mirghani, F. Amen, F. Moreau, J. Guigay, D.M. Hartl, and J. Lacau St Guily Oropharyngeal cancers: relationship between epidermal growth factor receptor alterations and human papillomavirus status Eur J Cancer 50 2014 1100 1111
69. C.C. Ragin, and E. Taioli Survival of squamous cell carcinoma of the head and neck inrelation to human papillomavirus infection: review and meta-analysis Int J Cancer 121 2007 1813 1820
70. C. Fakhry, W.H. Westra, and S. Li Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 2008 261 264
71. H. Nave, A. Gebert, and R. Pabst Morphology and immunology of the human palatine tonsil Anatomy Embryol 204 2001 367 373
72. A.C. Jung, S. Guihard, and S. Krugell CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis Int J Cancer 132 2013 26 36
73. E. Kaminagakura, L.L. Villa, and M.A. Andreoli High-risk human papillomavirus in oral squamous cell carcinoma of young patients Int J Cancer 130 2012 1726 1732
74. A. Duray, G. Descamps, and C. Decaestecker Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma Laryngoscope 122 2012 1558 1565
75. M. Sugiyama, U.K. Bhawal, and M. Kawamura Human papillomavirus-16 in oral squamous cell carcinoma: clinical correlates and 5-year survival Br J Oral Maxillofac Surg 45 2007 116 122
76. C.H. Chung, Q. Zhang, and C.S. Kong p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma J Clin Oncol 2014 pii: JCO.2013.54.5228 (in press)
77. M. Herfs, Y. Yamamoto, and A. Laury A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer Proc Natl Acad Sci USA 109 2012 10516 10521
78. S.H. Kim, B.S. Koo, S. Kang, K. Park, H. Kim, and K.R. Lee HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation Int J Cancer 120 2007 1418 1425
79. S. Begum, D. Cao, M. Gillison, M. Zahurak, and W.H. Westra Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma Clinicalcancer Res: Off J Am Assoc Cancer Res 11 2005 5694 5699
80. K. Patel, S. Ariyaratnam, P. Sloan, and M.N. Pemberton Oral tonsils (ectopic oral tonsillar tissue) Dent Update 31 2004 291 292
81. K. Mogi Ectopic tonsillar tissue in the mucosa of the floor of the mouth simulating a benign tumour: case report Aust Dent J 36 1991 456 458
82. A.S. Andersen, A.S. Koldjaer Sølling, T. Ovesen, and M. Rusan The interplay between HPV and host immunity in head and neck squamous cell carcinoma Int J Cancer 134 2014 2755 2763
83. S.I. Pai Mission impossible: how HPV-associated head and neck cancers escape a primed immune response Oral Oncol 49 2013 723 725